<DOC>
	<DOCNO>NCT01748279</DOCNO>
	<brief_summary>Rationale : Retrospective study suggest statin improve outcome COPD patient possibly result anti-inflammatory effect . Objectives : To determine whether statin anti-inflammatory effect lung patient COPD . A control , parallel group study compare effect Atorvastatin comparison placebo add-on treatment Formoterol therapy patient mild moderate COPD group 20 patient . All subject spirometry , lung volume , DLCO , SGRQ , 6MWD , serum lipid hs-CRP measured treatment . Bronchoscopy transbronchial lung biopsy ( TBB ) carry baseline 12 week treatment , TBB specimens process histology , immunohistochemistry microarray analysis .</brief_summary>
	<brief_title>The Effects Atorvastatin Treatment COPD Patients</brief_title>
	<detailed_description />
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>. Written informed consent must obtain assessment perform . 2 . Male female adult age ≥40 year , sign Informed Consent Form prior initiation studyrelated procedure . 3 . Patients moderate severe stable COPD ( Stage IIIV ) accord GOLD guideline . 4 . Patients postbronchodilator FEV1 &lt; 80 % predict normal , postbronchodilator FEV1/FVC &lt; 0.70 Visit 1 . 5 . Current exsmokers smoke history least 10 pack year Exclusion criteria 1 . Pregnant nursing ( lactate ) woman 2 . Women childbearing potential , unless use effective method contraception dose study treatment . 5 . 3 . Patients clinically significant abnormality Visit 1 . 4 . Patients clinically relevant laboratory abnormality Visit 1 5 . Patients history malignancy organ system ( include lung cancer ) . 6 . Patients contraindicate treatment statin 7 . Patients unable perform acceptable spirometry lung volume procedure . 8 . Patients COPD exacerbation require treatment antibiotic and/or oral corticosteroid and/or hospitalization 6 week prior Visit 1 . 9 . Patients respiratory tract infection within 4 week prior Visit 1 . 10 . Patients require oxygen therapy ( &gt; 15 hr/day ) daily basis chronic hypoxemia 11 . Patients history asthma onset symptom prior age 40 year . 12 . Patients concomitant pulmonary disease , ( e.g . lung fibrosis , sarcoidosis , interstitial lung disease , pulmonary hypertension , tuberculosis ) . 13 . Patients primary bronchiectasis . 14 . Patients diagnosis α1 antitrypsin deficiency . 15 . Patients pulmonary lobectomy lung volume reduction surgery lung transplantation . 16 . Patients participate plan participate active phase supervise pulmonary rehabilitation program study . 17 . Patients receive medication class list Table 5.1 18 . Use investigational drug within 30 day prior visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>COPD</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>statin</keyword>
	<keyword>COPD treatment</keyword>
	<keyword>microarrays</keyword>
</DOC>